We therefore examined the participation of C2-O- sLeX in E-selectin binding of LS174T and HepG2 cells by detecting the ability of these carcinoma cell lines expressing C2-O-sLeX to bind to a mouse E-selectin Fc chimera by flow cytometry. The gene discussed is SELE; the disease is carcinoma.